SCHEMBL8244

SCHEMBL8244

CC(=O)CC(N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6027700 1.00
SCHEMBL6028073 1.00
SCHEMBL30391170 0.97 GRIK1 (0.58)
SCHEMBL28659265 0.97 GRIK1 (0.58)
Hydrochloric Acid SCHEMBL376814 0.97 GRIK1 (0.58)
Phosphoric Acid SCHEMBL2150696 0.91 GRIK1 (0.52)
SCHEMBL29098570 0.87 GRIK1 (0.48)
SCHEMBL874270 0.84 SLC7A5 (0.58)
SCHEMBL21447999 0.84 SLC7A5 (0.58)
SCHEMBL877833 0.84 SLC7A5 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 40155 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4748859-A2 CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF The Regents of the University of California (US) 2026-05-27 EP claimed
EP-4747380-A1 MODULATING EXPRESSION OF ALAS1 (5'-AMINOLEVULINATE SYNTHASE 1) GENE CRISPR Therapeutics AG (CH) 2026-05-27 EP claimed
CN-122081366-A 5-Aminolevulinic acid production strain and construction method and application thereof 2026-05-26 CN claimed
US-20260137794-A1 LIGAND-DRUG CONJUGATE AND USE THEREOF SYSTIMMUNE INC (US) 2026-05-21 US claimed
EP-4743490-A1 HUMANIZED ANTI-CD7 ANTIBODY Christian-Albrechts-Universität zu Kiel (DE) 2026-05-20 EP claimed
WO-2026099502-A1 NOVEL DRUG CONJUGATES FOR TESTING CELLULAR DRUG UPTAKE Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2026-05-15 WO claimed
US-20260132141-A1 PROTEIN PHOSPHATASE 2A ACTIVATORS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2026-05-14 US claimed
US-12623094-B2 Incoherent field sonodynamic therapy for treating cancer Alpheus Medical, Inc. (US) 2026-05-12 US claimed
US-20260116861-A1 ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) 2026-04-30 US claimed
US-20260108619-A1 CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS HANGZHOU DAC BIOTECH CO., LTD. (CN) 2026-04-23 US claimed
WO-1993001310-A1 LEAD ASSAY UNIVERSITY OF MARYLAND AT BALTIMORE (US) 1993-01-21 WO claimed
WO-1991016820-A1 PHOTODYNAMIC PLANT DEFOLIANTS AND CHLOROPHYLL BIOSYNTHESIS MODULATORS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 1991-11-14 WO claimed
EP-0326835-A1 Porphyric insecticides The Board of Trustees for the University of Illinois (US) 1989-08-09 EP claimed
US-4849348-A Post-transcriptional heme regulated heterologous gene expression in yeast using the leg hemoglobin leader sequence A/S DE DANSKE SUKKERFABRIKKER (DK) 1989-07-18 US claimed
WO-1988008450-A1 GENE THERAPY FOR METABOLITE DISORDERS FINLAYSON BIRDWELL (US) 1988-11-03 WO claimed
EP-0042626-B1 ANTICONVULSIVE COMPOSITIONS NEW YORK UNIVERSITY (US) 1986-05-21 EP claimed
EP-0162920-A1 METHOD OF CATALYZING CHEMICAL REACTIONS IGEN, INC. (a California corporation) (US) 1985-12-04 EP claimed
WO-1985002414-A1 METHOD OF CATALYZING CHEMICAL REACTIONS IGEN, INC. (US) 1985-06-06 WO claimed
US-4372974-A Anticonvulsive compositions and method of treating convulsive disorders NEW YORK UNIVERSITY (US) 1983-02-08 US claimed
EP-0042626-A2 Anticonvulsive compositions NEW YORK UNIVERSITY (US) 1981-12-30 EP claimed